Skip to content

Aldental

Active
Private limited companyfounded 200421 yrs activeOude-Bruglaan 72, 9160 Lokeren, BelgiumKBO/BCE: BE 0867.765.265
Summary

Aldental has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €606k and a net result of €117k. Equity is growing by ~9.9% per year across the filed fiscal years. Its solvency ranks better than 62% of 2344 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability86▲+4
Solvency98=
Growth52=
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 2.88 against 2.57 in 2024; short-term debt: 26.5% and cash: 24.2% of total assets), and 27.1% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 21 years 0 30 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
72.9%
Return on assets
14.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
7 d early
2024
2 d early
2023
20 d early
2022
11 d early
2021
3 d early
2020
5 d early
2019
22 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€606k▲ 24.0%
2024 · €489k
2018: €346k 2019: €286k▼ -17.3% vs 2018lowest in 8 years 2020: €350k▲ +22.2% vs 2019 2021: €364k▲ +4.0% vs 2020 2022: €404k▲ +11.0% vs 2021 2023: €419k▲ +3.8% vs 2022 2024: €489k▲ +16.7% vs 2023 2025: €606k▲ +24.0% vs 2024highest in 8 years
2018 → 2025
Total assets
€831k▲ 24.1%
2024 · €670k
2018: €866k 2019: €873k▲ +0.8% vs 2018highest in 8 years 2020: €582k▼ -33.4% vs 2019 2021: €579k▼ -0.6% vs 2020 2022: €533k▼ -7.8% vs 2021lowest in 8 years 2023: €739k▲ +38.5% vs 2022 2024: €670k▼ -9.3% vs 2023 2025: €831k▲ +24.1% vs 2024
2018 → 2025
Net result
€117k▲ 67.6%
2024 · €70k
2018: €163k 2019: €-60k▼ -137% vs 2018lowest in 8 years 2020: €64k▲ +206% vs 2019 2021: €94k▲ +47.6% vs 2020 2022: €62k▼ -34.1% vs 2021 2023: €190k▲ +208% vs 2022highest in 8 years 2024: €70k▼ -63.3% vs 2023 2025: €117k▲ +67.6% vs 2024
2018 → 2025
Working capital
€413k▲ 51.9%
2024 · €272k
2018: €-83k 2019: €-122k▼ -47.0% vs 2018lowest in 8 years 2020: €52k▲ +143% vs 2019 2021: €73k▲ +39.5% vs 2020 2022: €157k▲ +116% vs 2021 2023: €216k▲ +37.7% vs 2022 2024: €272k▲ +26.1% vs 2023 2025: €413k▲ +51.9% vs 2024highest in 8 years
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€364k-€404k▲ 11.0%€419k▲ 3.8%€489k▲ 16.7%€606k▲ 24.0% 2021: €364klowest in 5 years 2022: €404k▲ +11.0% vs 2021 2023: €419k▲ +3.8% vs 2022 2024: €489k▲ +16.7% vs 2023 2025: €606k▲ +24.0% vs 2024highest in 5 years
Operating result€98k-€75k▼ 23.6%€191k▲ 156%€89k▼ 53.7%€112k▲ 26.7% 2021: €98k 2022: €75k▼ -23.6% vs 2021lowest in 5 years 2023: €191k▲ +156% vs 2022highest in 5 years 2024: €89k▼ -53.7% vs 2023 2025: €112k▲ +26.7% vs 2024
Net result€94k-€62k▼ 34.1%€190k▲ 208%€70k▼ 63.3%€117k▲ 67.6% 2021: €94k 2022: €62k▼ -34.1% vs 2021lowest in 5 years 2023: €190k▲ +208% vs 2022highest in 5 years 2024: €70k▼ -63.3% vs 2023 2025: €117k▲ +67.6% vs 2024
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150k€200kOperating result 2021: €98k€98kNet result 2021: €94k€94kOperating result 2022: €75k€75kNet result 2022: €62k€62kOperating result 2023: €191k€191kNet result 2023: €190k€190kOperating result 2024: €89k€89kNet result 2024: €70k€70kOperating result 2025: €112k€112kNet result 2025: €117k€117k20212022202320242025€0€50k€100k€150k€200kOperating result 2023: €191k€191kNet result 2023: €190k€190kOperating result 2024: €89k€89kNet result 2024: €70k€70kOperating result 2025: €112k€112kNet result 2025: €117k€117k202320242025
The operating result recovers in 2025; 2025 is 27% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €831k
Fixed assets €198k ▼ 11.7%
Current assets €633k ▲ 42.1%
Equity and liabilities €831k
Equity €606k ▲ 24.0%
Debt €225k ▲ 24.3%
Debt's share of the balance-sheet total stays at 27.1%.
Key figures and ratios
2025 value · change against 2024
EBITDA
€172k▲
2024 · €142k
Cash flow
€177k▲
2024 · €123k
Current ratio
2.88▲
2024 · 2.57
Quick ratio
2.23▲
2024 · 2.01
Debt to equity
0.37▲
2024 · 0.37
ROE
19.3%▲
2024 · 14.3%
ROA
14.1%▲
2024 · 10.4%
Interest coverage
29.47▼
2024 · 75.75
Debt ≤ 1 year
€220k▲
2024 · €174k
Income taxes
€0▼
2024 · €28k
Staff costs
€307k▲
2024 · €304k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 56 lines
Balance sheet Code20242025
Assets
Total assets20/58€670k€831k▲
Fixed assets21/28€225k€198k▼
Tangible fixed assets22/27€216k€189k▼
Plant, machinery and equipment23€100k€98k▼
Furniture and vehicles24€12k€8k▼
Other tangible fixed assets26€104k€83k▼
Financial fixed assets28€9k€9k=
Current assets29/58€446k€633k▲
Amounts receivable after more than one year29€150k€150k=
Other amounts receivable291€150k€150k=
Stocks and contracts in progress3€96k€142k▲
Stocks30/36€96k€142k▲
Amounts receivable within one year40/41€147k€129k▼
Trade receivables40€81k€84k▲
Other amounts receivable41€66k€45k▼
Cash at bank and in hand54/58€37k€202k▲
Deferred charges and accrued income490/1€16k€10k▼
Equity and liabilities
Total equity and liabilities10/49€670k€831k▲
Equity10/15€489k€606k▲
Contributions10/11€19k€19k=
Reserves13€468k€585k▲
Tax-exempt reserves132€69k€69k=
Distributable reserves133€399k€516k▲
Profit (loss) carried forward14€3k€3k▲
Amounts payable17/49€181k€225k▲
Amounts payable within one year42/48€174k€220k▲
Trade debts44€105k€168k▲
Suppliers440/4€105k€168k▲
Advances received on contracts in progress46€4k€8k▲
Taxes, remuneration and social security45€65k€44k▼
Taxes450/3€28k€3k▼
Remuneration and social security454/9€37k€40k▲
Other amounts payable47/48€0-
Accrued charges and deferred income492/3€8k€5k▼
Income statement Code20242025
Non-recurring operating income76A€29€0▼
Remuneration, social security and pensions62€304k€307k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€53k€60k▲
Other operating charges640/8€6k€4k▼
Non-recurring operating charges66A-€18k
Gross operating margin9900€452k€500k▲
Operating profit (loss)9901€89k€112k▲
Financial income75/76B€11k€11k▼
Recurring financial income75€11k€11k▼
Financial charges65/66B€2k€6k▲
Recurring financial charges65€2k€6k▲
Profit (loss) for the period before taxes9903€98k€117k▲
Income taxes67/77€28k€0▼
Profit (loss) for the period9904€70k€117k▲
Profit (loss) for the period to be appropriated9905€70k€117k▲
Appropriation of the result
Profit (loss) to be appropriated9906€72k€120k▲
Profit (loss) brought forward from the previous period14P€2k€3k▲
Transfer to equity691/2€69k€117k▲
To other reserves6921€69k€117k▲
Profit to be distributed694/7€0-
Directors or managers695€0-
Social balance
Average headcount (FTE)90873.44.4▲

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Non-recurring operating income76A---€29€0▼ 100%
Remuneration, social security and pensions62€252k€228k€252k€304k€307k▲ 0.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€68k€61k€63k€53k€60k▲ 12.7%
Other operating charges640/8€19k€8k€3k€6k€4k▼ 39.3%
Non-recurring operating charges66A----€18k-
Gross operating margin9900€436k€371k€510k€452k€500k▲ 10.8%
Operating profit (loss)9901€98k€75k€191k€89k€112k▲ 26.7%
Financial income75/76B€1k€3k€6k€11k€11k▼ 3.4%
Recurring financial income75€1k€3k€6k€11k€11k▼ 3.4%
Financial charges65/66B€4k€4k€1k€2k€6k▲ 212%
Recurring financial charges65€4k€4k€1k€2k€6k▲ 212%
Profit (loss) for the period before taxes9903€95k€74k€197k€98k€117k▲ 19.8%
Income taxes67/77€1k€12k€6k€28k€0▼ 100%
Profit (loss) for the period9904€94k€62k€190k€70k€117k▲ 67.6%
Profit (loss) for the period to be appropriated9905€94k€62k€190k€70k€117k▲ 67.6%
Line20212022202320242025Change
Assets
Total assets20/58€579k€533k€739k€670k€831k▲ 24.1%
Fixed assets21/28€300k€251k€210k€225k€198k▼ 11.7%
Intangible fixed assets21€0-----
Tangible fixed assets22/27€291k€242k€201k€216k€189k▼ 12.2%
Plant, machinery and equipment23€111k€87k€72k€100k€98k▼ 1.7%
Furniture and vehicles24€2k€4k€6k€12k€8k▼ 29.9%
Other tangible fixed assets26€179k€151k€122k€104k€83k▼ 20.1%
Financial fixed assets28€9k€9k€9k€9k€9k=
Current assets29/58€278k€282k€528k€446k€633k▲ 42.1%
Amounts receivable after more than one year29€70k€110k€300k€150k€150k=
Other amounts receivable291€70k€110k€300k€150k€150k=
Stocks and contracts in progress3€74k€87k€86k€96k€142k▲ 48.2%
Stocks30/36€74k€87k€86k€96k€142k▲ 48.2%
Amounts receivable within one year40/41€49k€22k€62k€147k€129k▼ 12.0%
Trade receivables40€46k€16k€54k€81k€84k▲ 4.8%
Other amounts receivable41€3k€6k€8k€66k€45k▼ 32.4%
Cash at bank and in hand54/58€84k€53k€73k€37k€202k▲ 444%
Deferred charges and accrued income490/1€551€11k€6k€16k€10k▼ 34.7%
Equity and liabilities
Total equity and liabilities10/49€579k€533k€739k€670k€831k▲ 24.1%
Equity10/15€364k€404k€419k€489k€606k▲ 24.0%
Contributions10/11€19k€19k€19k€19k€19k=
Reserves13€344k€384k€399k€468k€585k▲ 25.0%
Non-distributable reserves130/1€2k€2k€0---
Reserves not available under the articles1311€2k€2k€0---
Tax-exempt reserves132€69k€69k€69k€69k€69k=
Distributable reserves133€274k€314k€330k€399k€516k▲ 29.3%
Profit (loss) carried forward14€695€577€2k€3k€3k▲ 10.3%
Amounts payable17/49€215k€130k€320k€181k€225k▲ 24.3%
Amounts payable after more than one year17€0-----
Other amounts payable178/9€0-----
Amounts payable within one year42/48€206k€126k€313k€174k€220k▲ 26.7%
Trade debts44€94k€58k€98k€105k€168k▲ 59.7%
Suppliers440/4€94k€58k€98k€105k€168k▲ 59.7%
Advances received on contracts in progress46€2k€377€1k€4k€8k▲ 113%
Taxes, remuneration and social security45€30k€45k€38k€65k€44k▼ 32.3%
Taxes450/3€1k€13k€6k€28k€3k▼ 88.0%
Remuneration and social security454/9€28k€32k€32k€37k€40k▲ 9.7%
Other amounts payable47/48€80k€22k€175k€0--
Accrued charges and deferred income492/3€9k€4k€7k€8k€5k▼ 31.5%
Line20212022202320242025Change
Profit (loss) for the period9904€94k€62k€190k€70k€117k▲ 67.6%
+ Depreciation and write-downs630€68k€61k€63k€53k€60k▲ 12.7%
Operating cash flow (approximation)€162k€122k€254k€123k€177k▲ 44.0%
Investment in fixed assets (approximation)-€-11k€-22k€-67k€-33k▲ 50.2%
Change in cash-€-31k€20k€-36k€165k▲ 554%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
24-07
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial Equity above €500kEq €606k ▲24%
6 profitable years in a row build equity to €606k.
29-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
07-07
State Gazette act Appointment: Moore Audit (statutory auditor)
Permanent representative: Sam Kwanten3 facts ▸
  • General meeting, 14-06-2024
  • Auditor appointment, Moore Audit (statutory auditor)
  • Permanent representative, Sam Kwanten
2024
11-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Highest result since 2018net €190k ▲208%
Net result €190k, the highest in the series.
21-11
State Gazette act Permanent representative: Jarkko Jokinen
Resignation: Patrick Bakker (permanent representative)3 facts ▸
  • Board meeting, 23-10-2023
  • Permanent representative, Jarkko Jokinen
  • Director resignation, Patrick Bakker (permanent representative)
25-08
State Gazette act Statutes amendment · Legal-form change
Legal-form conversion · Equity account conversion · Capital5 facts ▸
  • General meeting, 17-08-2023
  • Legal-form conversion, Besloten vennootschap met beperkte aansprakelijkheid
  • Equity account conversion, Omvorming van de statutair onbeschikbare eigen vermogensrekening in een beschikbare eigen vermogensrekening
  • Statutes amendment
  • Capital
20-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
24-04
State Gazette act Resignations: Patrick Bakker (director) and Maarten ter Haar (director)
Appointment: Colosseum Dental België (director) · Permanent representatives: Patrick Bakker and Sam Kwanten6 facts ▸
  • General meeting, 16-01-2023
  • Director resignation, Patrick Bakker (director)
  • Director resignation, Maarten ter Haar (director)
  • Director appointment, Colosseum Dental België (director)
  • Permanent representative, Patrick Bakker
  • Permanent representative, Sam Kwanten (statutory auditor)
2022
05-09
State Gazette act Resignations: Raoul Francis Dias (director) and Daniel Fehr (director)
3 facts ▸
  • General meeting, 29-07-2022
  • Director resignation, Raoul Francis Dias (director)
  • Director resignation, Daniel Fehr (director)
28-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
Show earlier events
09-03
State Gazette act Appointments: Maarten ter Haar (director) and Patrick Bakker (director)
3 facts ▸
  • General meeting, 21-01-2022
  • Director appointment, Maarten ter Haar (director)
  • Director appointment, Patrick Bakker (director)
17-02
State Gazette act Resignation: Prophylaxis Participations B.V. (director)
Permanent representative: Chris Cools · Director discharge4 facts ▸
  • General meeting, 22-10-2021
  • Director resignation, Prophylaxis Participations B.V. (director)
  • Permanent representative, Chris Cools
  • Director discharge, Prophylaxis Participations B.V.
11-01
State Gazette act Resignation: Dentconnect België BV (director)
Appointments: Daniel Fehr (director) and Raoul Dias (director)4 facts ▸
  • General meeting, 13-12-2021
  • Director resignation, Dentconnect België BV (director)
  • Director appointment, Daniel Fehr (director)
  • Director appointment, Raoul Dias (director)
2021
28-07
State Gazette act Reappointment: PKF-VMB BEDRIJFSREVISOREN (statutory auditor)
Permanent representative: Jeroen Van Der Hamsvoort3 facts ▸
  • General meeting, 28-06-2021
  • Auditor reappointment, PKF-VMB BEDRIJFSREVISOREN
  • Permanent representative, Jeroen Van Der Hamsvoort
26-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Back to profitnet €64k
Net result €64k after one loss-making year.
09-07
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
22-01
State Gazette act Resignation: Jeroen VAN DER HAMSVOORT (manager)
Appointment: Dentconnect België (manager) · Permanent representative: Jeroen VAN DER HAMSVOORT · Mandate compensation5 facts ▸
  • General meeting, 11-12-2019
  • Director resignation, Jeroen VAN DER HAMSVOORT (manager)
  • Director appointment, Dentconnect België (manager)
  • Permanent representative, Jeroen VAN DER HAMSVOORT
  • Mandate compensation, Dentconnect België
2019
31-12
Financial Weakest financial yearnet €-60k
Net result drops to €-60k, the lowest in the series; recovery starts the following year.
05-11
State Gazette act Resignations: Bart VAN DER AUWELAER (manager) and CRSG België B.V. (manager)
Appointments: Jeroen VAN DER HAMSVOORT (manager) and Curaeos B.V. (manager) · Permanent representative: Chris COOLS · Mandate compensation8 facts ▸
  • General meeting, 03-10-2019
  • Director resignation, Bart VAN DER AUWELAER (manager)
  • Director resignation, CRSG België B.V. (manager)
  • Director appointment, Jeroen VAN DER HAMSVOORT (manager)
  • Director appointment, Curaeos B.V. (manager)
  • Permanent representative, Chris COOLS (permanent representative)
  • Mandate compensation, Jeroen VAN DER HAMSVOORT
  • Mandate compensation, Curaeos B.V.
30-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
07-02
State Gazette act Appointment: PKF-VMB Bedrijfsrevisoren (statutory auditor)
Permanent representative: Luc Martens3 facts ▸
  • General meeting, 01-10-2018
  • Auditor appointment, PKF-VMB Bedrijfsrevisoren (statutory auditor)
  • Permanent representative, Luc Martens
07-02
State Gazette act Registered office
Registered-office move1 fact ▸
  • Registered-office move, Oude Bruglaan 72 bus 0101, 9160 Lokeren
2018
31-12
State Gazette act Permanent representative: Bart Borms
Power of attorney3 facts ▸
  • General meeting, 29-11-2018
  • Permanent representative, Bart Borms (permanent representative)
  • Power of attorney, Allen & Overy LLP
03-12
State Gazette act Resignation: DCH België B.V. (manager)
2 facts ▸
  • General meeting, 02-11-2018
  • Director resignation, DCH België B.V. (manager)
13-06
State Gazette act Resignation: PDW DENTALIM (non-statutory manager)
Appointments: CRSG België B.V., DCH België B.V. and Van der Auwelaer, Bart · Permanent representatives: Vermeule, Jacob Adelbertus Cornelis and George, Jerry Mathen · Registered-office move17 facts ▸
  • General meeting, 09-05-2018
  • Registered-office move, 9160 Lokeren, Knokkestraat 34
  • Purpose change, De vennootschap heeft tot doel in België en in het buitenland, uitsluitend in eigen naam en voor eigen rekening: a)het opzetten en exploiteren van voorzíeningen…
  • Statutes amendment
  • Statutes amendment
  • Director resignation, PDW DENTALIM (non-statutory manager)
  • Statutes amendment
  • Capital, €18.600
  • Director appointment, CRSG België B.V. (non-statutory manager)
  • Permanent representative, Vermeule, Jacob Adelbertus Cornelis
  • Director appointment, DCH België B.V. (non-statutory manager)
  • Permanent representative, George, Jerry Mathen
  • +5 further facts in this act
30-01
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
28-06
State Gazette act Resignation: DE WITTE PETER (director)
Appointment: PDW DENTALIM (director) · Permanent representative: Peter De Witte4 facts ▸
  • General meeting, 01-03-2017
  • Director resignation, DE WITTE PETER (director)
  • Director appointment, PDW DENTALIM (director)
  • Permanent representative, Peter De Witte (vaste vertegenwoordiger voor de uitoefening van het mandaat van zaakvoerder)
23-01
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
2013
14-05
State Gazette act Resignation: Chaffart Karin Tandarts CommV. (manager)
Appointment: De Witte Peter BVBA (manager) · Permanent representative: De Witte Peter4 facts ▸
  • General meeting, 16-04-2013
  • Director resignation, Chaffart Karin Tandarts CommV. (manager)
  • Director appointment, De Witte Peter BVBA (manager)
  • Permanent representative, De Witte Peter
2012
02-03
State Gazette act Permanent representatives: Peter De Witte and Karin Chaffart
Resignations: Peter De Witte (manager) and Karin Chaffart (manager) · Appointments: De Witte Peter BV ovv BVBA (manager) and Chaffart Karin Tandarts Comm.V. (manager) · Director discharge14 facts ▸
  • Board meeting, 01-07-2011
  • Permanent representative, Peter De Witte (permanent representative)
  • General meeting, 01-07-2011
  • Director resignation, Peter De Witte (manager)
  • Director discharge, Peter De Witte
  • Director appointment, De Witte Peter BV ovv BVBA (manager)
  • Permanent representative, Peter De Witte (permanent representative)
  • Board meeting, 01-01-2012
  • Permanent representative, Karin Chaffart (permanent representative)
  • General meeting, 01-01-2012
  • Director resignation, Karin Chaffart (manager)
  • Director discharge, Karin Chaffart
  • +2 further facts in this act
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
19 of 20 acts read
About the unread acts

Of the 20 Belgian State Gazette acts we know for this company, 19 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
7 directors, last change in 2022
Raoul Dias
Director · since 13-12-2021
Current
Colosseum Dental België
Director · since 30-09-2019 · Private limited company · perm. rep.: Patrick Bakker
Current
Curaeos B.V.
Manager · since 30-09-2019 · Legal entity · perm. rep.: Chris COOLS
Not recently confirmed
Jeroen van der Hamsvoort
Manager · since 30-09-2019
Not recently confirmed
Van der Auwelaer, Bart
Non-statutory manager · since 03-05-2018
Not recently confirmed
PDW DENTALIM
Director · since 01-03-2017 · Private limited company · perm. rep.: Peter De Witte
Not recently confirmed
1 other director
De Witte Peter BVBA
Manager · since 16-04-2013 · Legal entity · perm. rep.: De Witte Peter
Not recently confirmed
01-09-2022 Colosseum Dental België: Appointed as Director
01-09-2022 Maarten ter Haar: Resigned as Director
01-09-2022 Patrick Bakker: Resigned as Director
29-07-2022 Daniel Fehr: Resigned as Director
29-07-2022 Raoul Francis Dias: Resigned as Director
Full history in the Timeline (28 changes) →
Not every act has been read: a resignation may be missing here
1 of this company's 20 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Lokeren · 1 establishment unit since 2004
seat establishment The establishment unit on the map
Ground area
420 m²
Building footprint
399 m²
Volume, LiDAR
1,793 m³
Parcel 46014A2143/00A000, Flanders · tallest building 9.7 m, ±2 floors. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Oude-Bruglaan 72, 9160 Lokeren
NACE 85130
since 20042.229.520.056
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
46014A2143/00A000 Flanders 420 m² 1 · 399 m² 9.7 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Statutory auditor

1 auditor
Moore AuditCurrent
Statutory auditor · represented by Sam Kwanten
14-06-2024 → present

Articles of association

Purpose
A) het opzetten en exploiteren van voorzieningen en organisaties voor de gezondheidszorg waarin medische specialisten onderzoeken en/of behandelingen in het domein van de…
Full purpose

A) het opzetten en exploiteren van voorzieningen en organisaties voor de gezondheidszorg waarin medische specialisten onderzoeken en/of behandelingen in het domein van de tandheelkunde hun activiteiten kunnen verrichten... b) het mogelijk maken van het uitoefenen van een tandartsenpraktijk... c) de opzetting en de exploitatie van een tandheelkundige praktijk... De vennootschap heeft eveneens tot voorwerp: a) ...beheren van een onroerend vermogen... b) ...beheren van een roerend vermogen... c) ...het aangaan en verstrekken van leningen...

Structure & network

Connections & network

5 connected companies
Linked via shared directors
ConsTand
Shared director
→
→
→
→
Show 1 more companies with a shared director
TANDHEELKUNDIG CENTRUM
Shared director
→

Capital and shareholders

Capital over the years
  1. 25-08-2023 Capital stated in the act · 100 shares
  2. 13-06-2018 Capital stated in the act · 18,600 EUR · 100 shares

Similar companies · same sector, comparable size

Of 6,942 companies in sector 86230 we hold annual accounts for 4,293. 3,361 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded12-10-2004
Fiscal year end31-12
Activities, NACEBEL 2025
86230Dental practice

Scores and ratios are computed by Checked and are not a credit decision.